Statistics for OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study

Total visits

views
OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study 194

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for th.pdf 186
java.util.UUID:b00d89d5-0267-4840-8afa-ba82de5cfc46 61
java.util.UUID:0d13e098-1ba9-4926-94b7-5a4e8844126f 21
java.util.UUID:cc1efee0-ec01-4b9e-b342-94abf6301324 8

Top country views

views
United States 149
China 8
Ukraine 5
Germany 4
United Kingdom 3
Canada 2
Italy 1
Malaysia 1
Russia 1
Sweden 1

Top city views

views
Wilmington 52
Fairfield 22
Houston 12
Cambridge 7
Shenzhen 6
Jacksonville 5
Kiev 5
Ann Arbor 3
Kiez 3
Lake Mary 3
Beijing 2
Brooklyn 2
Indianapolis 2
Seattle 2
Toronto 2
Washington 2
Augusta 1
Gunzenhausen 1
Saint Petersburg 1
San Francisco 1
Scottsdale 1
Seremban 1
Settimo Torinese 1
Stockholm 1